The acute myocardial infarction with ST segment elevation udine registry (Come-to-Udine): Predictors of 3 years mortality

Journal of Cardiovascular Medicine

Volumn 10, Issue 6, 2009, Pages 474-484

  Bernardi, Guglielmo ^a   Di Chiara, Antonio ^a   Armellini, Ilaria ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute myocardial infarction; Hub and spoke; Percutaneous coronary intervention; Thrombolysis

Indexed keywords

ABCIXIMAB; HEPARIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; COMPARATIVE STUDY; CONTROLLED STUDY; DECISION MAKING; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART RUPTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION; STROKE; COMMUNITY HOSPITAL; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; ITALY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PATIENT TRANSPORT; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; FEMALE; HEALTH CARE RATIONING; HEALTH SERVICES ACCESSIBILITY; HOSPITALS, COMMUNITY; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PATIENT TRANSFER; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 67649148270     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32832a56c9     Document Type: Article

References (47)

1. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and inhospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27:779-788.
2. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361:13-20. (Pubitemid 36050955)
3. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med 1996; 335:1253-1260.
4. Van de WF, Gore JM, Avezum A, Gulba DC, Goodman SG, Budaj A, et al. Access to catheterisation facilities in patients admitted with acute coronary syndrome: Multinational Registry Study. BMJ 2005; 330:441. (Pubitemid 40314207)
5. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002; 360:825-829. (Pubitemid 35257945)
6. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM Randomized Clinical Trial. Circulation 2003; 108:2851-2856. (Pubitemid 37517811)
7. Danchin N, Blanchard D, Steg PG, Sauval P, Hanania G, Goldstein P, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 2004; 110:1909-1915.
8. Stenestrand U, Lindback J, Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006; 296:1749-1756. (Pubitemid 44547795)
9. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297:1892-1900.
10. Zhan R, Schiele R, Schneider S, Gitt AK, Heer T, Wienbergen H, et al. Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA Trial. Z Kardiol 2002; 91:49-57.
11. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006; 367:569-578.
12. Fontanelli A, Bernardi G, Di Chiara A, Morocutti G. Primary percutaneous transluminal coronary angioplasty in acute myocardial infarction: immediate and short-term results. National experience. Cardiologia 1994; 39 (12 Suppl 1):427-434.
13. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21:1502-1513.
14. Di Chiara A, Zonzin P, Pavoni D, Fioretti PM, for the Gruppo di Studio e del Comitato Scientifico del Progetto RUTA. The RUTA (Registro UTIC Triveneto ANMCO) project: the Electronic Registry of Coronary Intensive Care Units of Triveneto Region for ST Elevation Acute Myocardial Infarction. Ital Heart J 2003; 4:481-494.
15. Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen HR, Nielsen TT, et al. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation 2005; 112:2017-2021.
16. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34:890-911. (Pubitemid 29436200)
17. Di Chiara A, Chiarella F, Savonitto S, Lucci D, Bolognese L, De Servi S, et al. Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ Study. Eur Heart J 2003; 24:1616-1629. (Pubitemid 37174901)
18. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH, Krumholz HM. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005; 111:761-767. (Pubitemid 40250637)
19. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006; 114:2019-2025.
20. Antman EM, Cooper HA, Gibson CM, de Lemos JA, McCabe CH, Giugliano RP, et al. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J 2002; 23:928-933.
21. Oude Ophuis TJ, Bar FW, Vermeer F, Krijne R, Jansen W, de Swart H, et al. Early referral for intentional rescue PTCA after initiation of thrombolytic therapy in patients admitted to a community hospital because of a large acute myocardial infarction. Am Heart J 1999; 137:846-853. (Pubitemid 29226294)
22. Vermeer F, Oude Ophuis AJ, vd Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 1999; 82:426-431.
23. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, et al. A randomized trial comparing primary angioplasty with a strategy of shortacting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT Investigators. Plasminogenactivator Angioplasty Compatibility Trial. J Am Coll Cardiol 1999; 34:1954-1962.
24. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI Study). J Am Coll Cardiol 2005; 46:417-424. (Pubitemid 41040280)
25. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003; 42:634-641. (Pubitemid 37000177)
26. Magnesium in Coronaries (MAGIC) Trial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 2002; 360:1189-1196.
27. Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA 2001; 286:1356-1359. (Pubitemid 33015527)
28. Zahn R, Schiele R, Seidl K, Kapp T, Glunz HG, Jagodzinski E, et al. Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. J Am Coll Cardiol 2000; 35:1820-1826.
29. Olivari Z, Di Pede F, Schievano E, Brocco S, Ramondo A, La Vecchia L, et al. Hospital epidemiology of ST-segment elevation myocardial infarction and feasibility of primary percutaneous coronary intervention in an interhospital network: data from a multicenter, prospective and observational study VENERE (VENEto Acute Myocardial Infarction Registry). Ital Heart J 2005; 6 (Suppl 6):57S-64S.
30. Zahn R, Schiele R, Schneider S, Gitt AK, Heer T, Wienbergen H, et al. Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). Herz 2000; 25:667-675.
31. Manari A, Ortolani P, Guastaroba P, Casella G, Vignali L, Varani E, et al. Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network. Eur Heart J 2008; 29:1834-1842.
32. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23:1190-1201. (Pubitemid 35215245)
33. Gottwik M, Zahn R, Schiele R, Schneider S, Gitt AK, Fraunberger L, et al. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) registries and the Myocardial Infarction Registry (MIR). Eur Heart J 2001; 22:1794-1801.
34. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349:733-742. (Pubitemid 37010777)
35. Danchin N, Coste P, Ferrieres J, Steg PG, Cottin Y, Blanchard D, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French Registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008; 118:268-276.
36. Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007; 357:1631-1638.
37. Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006; 355:2308-2320. (Pubitemid 44837779)
38. Khot UN, Johnson ML, Ramsey C, Khot MB, Todd R, Shaikh SR, et al. Emergency department physician activation of the catheterization laboratory and immediate transfer to an immediately available catheterization laboratory reduce door-to-balloon time in ST-elevation myocardial infarction. Circulation 2007; 116:67-76. (Pubitemid 47016248)
39. Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation 2007; 116:729-736.
40. Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, et al. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007; 116:721-728. (Pubitemid 47255989)
41. Fornaro G, Lazzero M, Giacalone A, Aralda D, Prando MD, Rossi L, et al. Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A postmortem study to verify cardiac rupture as a cause of death. G Ital Cardiol (Rome) 2008; 9:408-420.
42. Moreno R, Lopez dS, Lopez-Sendon JL, Garcia E, Soriano J, Abeytua M, et al. Frequency of left ventricular free-wall rupture in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 2000; 85:757-760; A8.
43. Morrow DA, Antman EM, Murphy SA, Assmann SF, Giugliano RP, Cannon CP, et al. The risk score profile: a novel approach to characterising the risk of populations enrolled in clinical studies. Eur Heart J 2004; 25:1139-1145.
44. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008; 117:296-329.
45. Di Pede F, Olivari Z, Schievano E, Spolaore P, Cacciavillani L, La Vecchia L, et al. Impact of reperfusion strategies on in-hospital outcome in STelevation myocardial infarction in a context of interhospital network: data from the prospective VENERE Registry (VENEto Acute Myocardial Infarction Registry). Ital Heart J Suppl 2005; 6:804-811.
46. Fernandez-Aviles F, Alonso JJ, Castro-Beiras A, Vazquez N, Blanco J, Alonso-Briales J, et al. Routine invasive strategy within 24 h of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004; 364:1045-1053. (Pubitemid 39248663)
47. Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early STelevation Myocardial Infarction Therapy) Study. Eur Heart J 2006; 27:1530-1538.